Used in research settings to modulate D-amino acid oxidase (DAAO) activity, particularly in studies related to schizophrenia and other neurological disorders where D-serine levels are implicated. Helps increase D-serine concentration in the brain by preventing its degradation, thereby enhancing NMDA receptor function. Employed in preclinical models to investigate cognitive improvement and glutamatergic transmission. Also utilized in combination with other agents to assess synergistic effects on neurotransmission and neuroprotection.